67 1. ABSTRACT 2. INTRODUCTION Phytochemicals in the Treatment Of
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Assessment Report on Salvia Officinalis L., Folium and Salvia Officinalis L., Aetheroleum Final
20 September 2016 EMA/HMPC/150801/2015 Committee on Herbal Medicinal Products (HMPC) Assessment report on Salvia officinalis L., folium and Salvia officinalis L., aetheroleum Final Based on Article 16d(1), Article 16f and Article 16h of Directive 2001/83/EC (traditional use) Herbal substance(s) (binomial scientific name of Salvia officinalis L., folium and the plant, including plant part) Salvia officinalis L., aetheroleum Herbal preparation(s) a) Comminuted herbal substance b) Liquid extract (DER 1:1), extraction solvent ethanol 70% V/V c) Dry extract (DER 4-7:1), extraction solvent water d) Liquid extract (DER 1:3.5-5), extraction solvent ethanol 31.5% V/V e) Liquid extract (DER 1:4-5) extraction solvent ethanol 50% V/V f) Liquid extract (DER 1:4-6), extraction solvent liquor wine:ethanol 96% V/V (38.25:61.75 m/m) g) Tincture (ratio of herbal substance to extraction solvent 1:10) extraction solvent ethanol 70% V/V Pharmaceutical form(s) Comminuted herbal substance as herbal tea for oral use. Comminuted herbal substance for infusion preparation for oromucosal or cutaneous use. Herbal preparations in solid or liquid dosage forms for oral use. Herbal preparations in liquid or semi-solid dosage forms for cutaneous use or for oromucosal use. 30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5555 Send a question via our website www.ema.europa.eu/contact An agency of the European Union © European Medicines Agency, 2017. Reproduction is authorised provided the source is acknowledged. -
Wogonin Attenuates Liver Fibrosis Via Regulating Hepatic Stellate Cell
International Immunopharmacology 75 (2019) 105671 Contents lists available at ScienceDirect International Immunopharmacology journal homepage: www.elsevier.com/locate/intimp Wogonin attenuates liver fibrosis via regulating hepatic stellate cell T activation and apoptosis Xiao-Sa Du, Hai-Di Li, Xiao-Juan Yang, Juan-Juan Li, Jie-Jie Xu, Yu Chen, Qing-Qing Xu, ⁎ Lei Yang, Chang-Sheng He, Cheng Huang, Xiao-Ming Meng, Jun Li The Key Laboratory of Major Autoimmune Diseases, Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, China The Key Laboratory of Anti-inflammatory of Immune Medicines, Ministry of Education, Institute for Liver Diseases of Anhui Medical University, China School of Pharmacy, Anhui Key Laboratory of Bioactivity of Natural Products, Anhui Medical University, Hefei 230032, China ARTICLE INFO ABSTRACT Keywords: Liver fibrosis is the representative features of liver chronic inflammation and the characteristic of early cirrhosis. Wogonin To date, effective therapy for liver fibrosis is lacking. Recently, Traditional Chinese Medicine (TCM)hasat- Liver fibrosis tracted increasing attention due to its wide pharmacological effects and more uses in clinical. Wogonin, asone Hepatic stellate cells (HSCs) major active constituent of Scutellaria radix, has been reported it plays an important role in anti-inflammatory, Apoptosis anti-cancer, anti-viral, anti-angiogenesis, anti-oxidant and neuro-protective effects. However, the anti-fibrotic effect of wogonin is never covered in liver. In this study, we evaluated the protect effect of wogonininliver fibrosis. Wogonin significantly attenuated liver fibrosis both4 inCCl -induced mice and TGF-β1 activated HSCs. Meanwhile, wogonin can enhances apoptosis of TGF-β1 activated HSC-T6 cell from rat and LX-2 cell from human detected by flow cytometry. -
Determination of Hispidulin in the Flowers of Inula Viscosa (L.) Aiton Using HPLC and HPTLC Methods
Turk J Pharm Sci 13(2), 159-166, 2016 Original article Determination of Hispidulin in the flowers of Inula viscosa (L.) Aiton Using HPLC and HPTLC Methods Alper GÖKBULUT Ankara University, Faculty of Pharmacy, Department of Pharmacognosy, 06100 Tandoğan, Ankara, TURKEY The flavone hispidulin (4´,5,7-trihydroxy-6-methoxyflavone) in the flowers of Inula viscosa (L.) Aiton was quantified by using High Performance Liquid Chromatography (HPLC), and also High Performance Thin-Layer Chromatography (HPTLC) fingerprint of the methanolic I. viscosa flower extract was presented. Both methods provided a rapid and easy approach for determination of the biomarker hispidulin. In the present study HPTLC and HPLC profiles of Inula viscosa flowers were presented to detect and quantify the small flavonoid hispidulin. The results reveal that I. viscosa flowers contain serious amount (0.151± 0.007 g/100 g dry weight) of hispidulin. Key words: Hispidulin, Inula viscosa, HPLC, HPTLC Inula viscosa (L.) Aiton Çiçeklerinde YPSK ve YPİTK Yöntemleri ile Hispidulin Analizi Inula viscosa (L.) Aiton çiçeklerinde bir flavon bileşiği olan hispidulin (4´,5,7-trihidroksi-6- metoksiflavon) miktarı Yüksek Performanslı Sıvı Kromatografisi (YPSK) ile tayin edilmiş, ayrıca I. viscosa çiçeklerinin metanolik ekstresinin Yüksek Performanslı İnce Tabaka Kromatografisi (YPİTK) parmakizi kromatogramı da verilmiştir. Her iki yöntem de biyo-işaretleyici bileşen olan hispidulinin belirlenmesi için hızlı ve kolay yaklaşımlar sağlamaktadır. Bu çalışmada küçük bir flavonoit bileşiği olan hispidulinin teşhis ve miktar tayinini gerçekleştirmek amacıyla I. viscosa çiçeklerinin YPİTK ve YPSK profilleri ortaya konmuştur. Sonuçlar, I. viscosa çiçeklerinin önemli ölçüde (0.151±0.007 g/100 g kuru ağırlık) hispidulin içerdiğini göstermektedir. Anahtar kelimeler: Hispidulin, Inula viscosa, YPSK, YPİTK Correspondence: E-mail: [email protected]; Tel: +903122033106 INTRODUCTION known as “yapışkan andız” and its fresh leaves are used for wound healing (25). -
Cardiovascular Disease Dyslipidemia | Non-Pharmacologic Treatment |
Cardiovascular Disease Dyslipidemia: Non-Pharmacologic Treatment Mark C. Houston, M.D., M.S. ABAARM, FACP, FACN, FAHA, FASH INTRODUCTION Cardiovascular disease (CVD) is the number one cause of morbidity and mortality in the United States,1 coronary heart disease (CHD) and myocardial infarction being the leading causes of death.1 The five major risk factors for CHD – hypertension, dyslipidemia, diabetes mellitus, smoking, and obesity – account for 80% of the risk for CHD.1,2 Interventions, both pharmacologic and nonpharmacologic, can improve all of these risk factors and decrease the incidence of CVD and its consequences, such as 3-6 myocardial infarction, angina, congestive heart failure and stroke. Recent guidelines by the National Cholesterol Education Program (NCEP) recommend more aggressive control of serum lipids to reduce the incidence of CHD.7 Nutritional and dietary therapy, weight loss, exercise, and scientifically-proven nutritional supplementation should be used initially in appropriately selected patients to manage dyslipidemia. Hypertriglyceridemia, which is frequently due to obesity, insulin resistance, metabolic syndrome and diabetes mellitus, deserves special attention.7 Pharmacologic therapy should be administered in those cases that are at high or very high-risk for CHD and those who do not respond to non-drug therapy. Many patients prefer non-drug therapies for many reasons including adverse effects of anti-lipid drugs, contraindications or allergic reactions to drugs, perceptions of adverse effects of drugs, or personal preference for natural or alternative therapies. A more aggressive integrative approach to the management of dyslipidemia is recommended to improve CHD outcomes, minimize adverse effects, and reduce health-care costs. NUTRITION AND EXERCISE Optimal nutrition and proper aerobic and resistance exercise form the cornerstone for the management of dyslipidemia. -
In Vivo Effect of PC-SPES on Prostate Growth and Hepatic CYP3A Expression in Rats
JPET Fast Forward. Published on April 3, 2003 as DOI: 10.1124/jpet.102.048645 JPETThis Fast article Forward. has not been Published copyedited and on formatted. April 3, The 2003 final asversion DOI:10.1124/jpet.102.048645 may differ from this version. JPET #48645 In Vivo Effect of PC-SPES on Prostate Growth and Hepatic CYP3A Expression in Rats Teri Wadsworth, Hataya Poonyagariyagorn, Elinore Sullivan, Dennis Koop and Charles E. Roselli. Downloaded from Department of Physiology and Pharmacology Oregon Health & Science University, Portland, OR. jpet.aspetjournals.org at ASPET Journals on September 26, 2021 1 Copyright 2003 by the American Society for Pharmacology and Experimental Therapeutics. JPET Fast Forward. Published on April 3, 2003 as DOI: 10.1124/jpet.102.048645 This article has not been copyedited and formatted. The final version may differ from this version. JPET #48645 Running Title: In vivo effects of PC-SPES Correspondence: Dr. Charles E. Roselli, Department of Physiology and Pharmacology L334, Oregon Health Sciences University, 3181 SW Sam Jackson Park Road, Portland, OR 97201-3098, Tel (503) 494-5837, FAX (503) 494-4352, email: [email protected] Number of text pages: 20 number of tables: 4 Downloaded from number of figures: 4 number of references: 40 jpet.aspetjournals.org number of words in the Abstract: 250 number of words the Introduction: 748 number of words in the Discussion: 1478 at ASPET Journals on September 26, 2021 nonstandard abbreviations: National Institute of Diabetes and Digestive and Kidney Disease (NIDDK); -
Inhibitory Effects of Phytochemicals on Metabolic Capabilities of CYP2D6*1 and CYP2D6*10 Using Cell-Based Models in Vitro
Acta Pharmacologica Sinica (2014) 35: 685–696 npg © 2014 CPS and SIMM All rights reserved 1671-4083/14 $32.00 www.nature.com/aps Original Article Inhibitory effects of phytochemicals on metabolic capabilities of CYP2D6*1 and CYP2D6*10 using cell-based models in vitro Qiang QU1, 2, Jian QU1, Lu HAN2, Min ZHAN1, Lan-xiang WU3, Yi-wen ZHANG1, Wei ZHANG1, Hong-hao ZHOU1, * 1Institute of Clinical Pharmacology, Hunan Key Laboratory of Pharmacogenetics, Xiangya Hospital, Central South University, Changsha 410078, China; 2Xiangya Hospital, Central South University, Changsha 410008, China; 3Institute of Life Sciences, Chongqing Medical University, Chongqing 400016, China Aim: Herbal products have been widely used, and the safety of herb-drug interactions has aroused intensive concerns. This study aimed to investigate the effects of phytochemicals on the catalytic activities of human CYP2D6*1 and CYP2D6*10 in vitro. Methods: HepG2 cells were stably transfected with CYP2D6*1 and CYP2D6*10 expression vectors. The metabolic kinetics of the enzymes was studied using HPLC and fluorimetry. Results: HepG2-CYP2D6*1 and HepG2-CYP2D6*10 cell lines were successfully constructed. Among the 63 phytochemicals screened, 6 compounds, including coptisine sulfate, bilobalide, schizandrin B, luteolin, schizandrin A and puerarin, at 100 μmol/L inhibited CYP2D6*1- and CYP2D6*10-mediated O-demethylation of a coumarin compound AMMC by more than 50%. Furthermore, the inhibition by these compounds was dose-dependent. Eadie-Hofstee plots demonstrated that these compounds competitively inhibited CYP2D6*1 and CYP2D6*10. However, their Ki values for CYP2D6*1 and CYP2D6*10 were very close, suggesting that genotype- dependent herb-drug inhibition was similar between the two variants. -
Baicalein Suppresses the Proliferation and Invasiveness of Colorectal Cancer Cells by Inhibiting Snail‑Induced Epithelial‑Mesenchymal Transition
2544 MOLECULAR MEDICINE REPORTS 21: 2544-2552, 2020 Baicalein suppresses the proliferation and invasiveness of colorectal cancer cells by inhibiting Snail‑induced epithelial‑mesenchymal transition QIONGYAO ZENG1,2, YU ZHANG3,4, WENJING ZHANG2,5 and QIANG GUO1-3 1Faculty of Life Science and Biotechnology; 2Faculty of Medicine, Kunming University of Science and Technology, Kunming, Yunnan 650500; 3Department of Gastroenterology, The First People's Hospital of Yunnan Province; 4Yunnan Provincial Institute of Digestive Medicine; 5Department of Medical Oncology, The First Peoples' Hospital of Yunnan Province, Kunming, Yunnan 650032, P.R. China Received June 7, 2019; Accepted March 6, 2020 DOI: 10.3892/mmr.2020.11051 Abstract. Scutellaria baicalensis (S. baicalensis) is a plant tion (EMT)-promoting factors including vimentin, Twist1, and that is widely used for medicinal purposes. Baicalein, one of Snail, but to upregulate the expression of E‑cadherin in CRC the primary bioactive compounds found in S. baicalensis, is cells. The expression levels of cell cycle inhibitory proteins thought to possess antitumor activity, although the specific p53 and p21 also increased following baicalein treatment. In mechanisms remain unclear. Therefore, the present study addition, Snail-induced vimentin and Twist1 upregulation, as aimed to evaluate the ability of baicalein to disrupt the prolif- well as E‑cadherin downregulation, were reversed following eration and metastatic potential of colorectal cancer (CRC) treatment with baicalein. In conclusion, the results of the cells; a rapid and sensitive ultra-high performance liquid present study indicate that baicalein may suppress EMT, at chromatography-tandem mass spectrometric method was least in part, by decreasing Snail activity. employed for the identification of baicalein in anS. -
SNI May-Jun-2011 Cover Final
OPEN ACCESS Editor-in-Chief: Surgical Neurology International James I. Ausman, MD, PhD For entire Editorial Board visit : University of California, Los http://www.surgicalneurologyint.com Angeles, CA, USA Review Article Stuck at the bench: Potential natural neuroprotective compounds for concussion Anthony L. Petraglia, Ethan A. Winkler1, Julian E. Bailes2 Department of Neurosurgery, University of Rochester Medical Center, Rochester, NY, 1University of Rochester School of Medicine and Dentistry, Rochester, NY, 2Department of Neurosurgery, North Shore University Health System, Evanston, IL, USA E-mail: *Anthony L. Petraglia - [email protected]; Ethan A. Winkler - [email protected]; Julian E. Bailes - [email protected] *Corresponding author Received: 29 August 11 Accepted: 22 September 11 Published: 12 October 11 This article may be cited as: Petraglia AL, Winkler EA, Bailes JE. Stuck at the bench: Potential natural neuroprotective compounds for concussion. Surg Neurol Int 2011;2:146. Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2011/2/1/146/85987 Copyright: © 2011 Petraglia AL. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Abstract Background: While numerous laboratory studies have searched for neuroprotective treatment approaches to traumatic brain injury, no therapies have successfully translated from the bench to the bedside. Concussion is a unique form of brain injury, in that the current mainstay of treatment focuses on both physical and cognitive rest. Treatments for concussion are lacking. The concept of neuro-prophylactic compounds or supplements is also an intriguing one, especially as we are learning more about the relationship of numerous sub-concussive blows and/or repetitive concussive impacts and the development of chronic neurodegenerative disease. -
(12) Patent Application Publication (10) Pub. No.: US 2006/0035981 A1 Mazzio Et Al
US 2006.0035981A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2006/0035981 A1 Mazzio et al. (43) Pub. Date: Feb. 16, 2006 (54) INHIBITION OF ANAEROBIC GLUCOSE Publication Classification METABOLISMAND CORRESPONDING COMPOSITIONAS ANATURAL NON-TOXC (51) Int. Cl. APPROACH TO CANCERTREATMENT A61 K 3L/I 2 (2006.01) A61K 31/7072 (2006.01) A61K 31/7076 (2006.01) A6IK 3I/525 (2006.01) (76) Inventors: Elizabeth Anne Mazzio, Tallahassee, A6IK 36/328 (2006.01) FL (US); Karam F. Soliman, A6IK 36/23 (2006.01) Tallahassee, FL (US) A61K 36/906 (2006.01) (52) U.S. Cl. .............................. 514/690; 514/45; 514/51; Correspondence Address: 514/27; 514/251; 424/725; Karam Soliman 424/748; 424/756; 424/745; Florida A& M University 424/746; 424/729 College of Pharmacy and Pharmaceutical (57) ABSTRACT Sciences This invention discloses a method and formulation for 104. Dyson Building treatment/prevention of human and animal cancers. The Tallahassee, FL 32307 (US) invention is designed to exploit the Vulnerability of cancer with regards to its anaerobic requirement for non-oxidative phosphorylation of glucose to derive energy, which is oppo (21) Appl. No.: 11/233,279 Site to the host. The composition is comprised of a combi nation of one or more of (A) 2,3-dimethoxy-5-methyl-1,4- benzoquinone, ubiquinones (5-45) (B) compound(s) capable (22) Filed: Sep. 20, 2005 of augmenting oxidative phosphorylation Such as a ribofla Vin containing compound and/or ubiquinone (50) (C) 2.3, 4'5,7-pentahydroxyflavone or a lactic acid dehydrogenase Related U.S. -
The Biological Activities and Therapeutic Potentials of Baicalein Extracted from Oroxylum Indicum: a Systematic Review
molecules Review The Biological Activities and Therapeutic Potentials of Baicalein Extracted from Oroxylum indicum: A Systematic Review Nik Nur Hakimah Nik Salleh , Farah Amna Othman, Nur Alisa Kamarudin and Suat Cheng Tan * School of Health Sciences, Health Campus, Universiti Sains Malaysia, Kubang Kerian 16150, Kelantan, Malaysia; [email protected] (N.N.H.N.S.); [email protected] (F.A.O.); [email protected] (N.A.K.) * Correspondence: [email protected]; Tel.: +60-9-7677776 Academic Editors: Giuseppe Caruso, Nicolò Musso and Claudia Giuseppina Fresta Received: 1 November 2020; Accepted: 23 November 2020; Published: 2 December 2020 Abstract: In Southeast Asia, traditional medicine has a longestablished history and plays an important role in the health care system. Various traditional medicinal plants have been used to treat diseases since ancient times and much of this traditional knowledge remains preserved today. Oroxylum indicum (beko plant) is one of the medicinal herb plants that is widely distributed throughout Asia. It is a versatile plant and almost every part of the plant is reported to possess a wide range of pharmacological activities. Many of the important bioactivities of this medicinal plant is related to the most abundant bioactive constituent found in this plant—the baicalein. Nonetheless, there is still no systematic review to report and vindicate the biological activities and therapeutic potential of baicalein extracted from O. indicum to treat human diseases. In this review, we aimed to systematically present in vivo and in vitro studies searched from PubMed, ScienceDirect, Scopus and Google Scholar database up to 31 March 2020 based on keywords “Oroxylum indicum” and “baicalein”. -
Flavonoids: Potential Candidates for the Treatment of Neurodegenerative Disorders
biomedicines Review Flavonoids: Potential Candidates for the Treatment of Neurodegenerative Disorders Shweta Devi 1,†, Vijay Kumar 2,*,† , Sandeep Kumar Singh 3,†, Ashish Kant Dubey 4 and Jong-Joo Kim 2,* 1 Systems Toxicology and Health Risk Assessment Group, CSIR-Indian Institute of Toxicology Research, Lucknow 226001, India; [email protected] 2 Department of Biotechnology, Yeungnam University, Gyeongsan, Gyeongbuk 38541, Korea 3 Department of Medical Genetics, SGPGIMS, Lucknow 226014, India; [email protected] 4 Department of Neurology, SGPGIMS, Lucknow 226014, India; [email protected] * Correspondence: [email protected] (V.K.); [email protected] (J.-J.K.); Tel.: +82-10-9668-3464 (J.-J.K.); Fax: +82-53-801-3464 (J.-J.K.) † These authors contributed equally to this work. Abstract: Neurodegenerative disorders, such as Parkinson’s disease (PD), Alzheimer’s disease (AD), Amyotrophic lateral sclerosis (ALS), and Huntington’s disease (HD), are the most concerning disor- ders due to the lack of effective therapy and dramatic rise in affected cases. Although these disorders have diverse clinical manifestations, they all share a common cellular stress response. These cellular stress responses including neuroinflammation, oxidative stress, proteotoxicity, and endoplasmic reticulum (ER)-stress, which combats with stress conditions. Environmental stress/toxicity weakened the cellular stress response which results in cell damage. Small molecules, such as flavonoids, could reduce cellular stress and have gained much attention in recent years. Evidence has shown the poten- tial use of flavonoids in several ways, such as antioxidants, anti-inflammatory, and anti-apoptotic, yet their mechanism is still elusive. This review provides an insight into the potential role of flavonoids against cellular stress response that prevent the pathogenesis of neurodegenerative disorders. -
Evidence for Aminopeptidase-N (CD13) Inhibition, Antiproliferative and Cell Death Properties
AIMS Molecular Science, 3(3): 368-385. DOI: 10.3934/molsci.2016.3.368 Received 17 May 2016, Accepted 28 July 2016, Published 1 August 2016 http://www.aimspress.com/journal/Molecular Research article In vitro activity of some flavonoid derivatives on human leukemic myeloid cells: evidence for aminopeptidase-N (CD13) inhibition, antiproliferative and cell death properties Sandrine Bouchet1,2, Marion Piedfer3, Santos Susin1, Daniel Dauzonne4,#, and Brigitte Bauvois1,#,* 1 Centre de Recherche des Cordeliers, INSERM UMRS1138, Sorbonne Universités UPMC Paris 06, Université Paris Descartes Sorbonne Paris Cité, F-75006 Paris, France 2 Assistance Publique des Hôpitaux de Paris, France 3 Centre de Recherche des Cordeliers, INSERM UMRS872 (2011-2012), Sorbonne Universités UPMC Paris 06, Université Paris Descartes Sorbonne Paris Cité, F-75006 Paris, France 4 Institut Curie, Departement Recherche, CNRS UMR3666, INSERM U1143, F-75005 Paris, France # Senior co-authorship. * Correspondence: Email: [email protected]; Tel: +33-144-273-138; Fax: +33-144-273-131. Abstract: Leukemia cells from patients with acute myeloid leukemia (AML) display high proliferative capacity and are resistant to death. Membrane-anchored aminopeptidase-N/CD13 is a potential drug target in AML. Clinical research efforts are currently focusing on targeted therapies that induce death in AML cells. We previously developed a non-cytotoxic APN/CD13 inhibitor based on flavone-8-acetic acid scaffold, the 2',3-dinitroflavone-8-acetic acid (1). In this context, among the variously substituted 113 compounds further synthesized and tested for evaluation of their effects on APN/CD13 activity, proliferation and survival in human AML U937 cells, eight flavonoid derivatives emerged: 2',3-dinitro-6-methoxy-flavone-8-acetic acid (2), four compounds (3–6) with the 3-chloro-2,3-dihydro-3-nitro-2-phenyl-4H-1-benzopyran-4-one structure, and three (7–9) with the 3-chloro-3,4-dihydro-4-hydroxy-3-nitro-2-phenyl-2H-1-benzopyran framework.